Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
Notified -
Globe Newswire27-05-2025, 19:30
VistaJet Celebrates 20 Years of Making Dreams with more Private World Voyages 21-08-2024, 16:00